Angio-oedema induced by oestrogen contraceptives is mediated by bradykinin and is frequently associated with urticaria

Dermatology

Volumn 225, Issue 1, 2012, Pages 62-69

  Giard, C ^a,c   Nicolie, B ^a,c   Drouet, M ^a,c   Lefebvre Lacoeuille, C ^a,c   Le Sellin, J ^a   Bonneau, J C ^a   Maillard, H ^b,c   Rnier, G ^a   Cichon, S ^f,g   Ponard, D ^c,d   Drouet, C ^c,e   Martin, L ^a,c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER DU MANS   (France)

^c French Reference Centre of Kinin Mediated Angio Oedemas   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e UNIV GRENOBLE ALPES   (France)

^f UNIVERSITY OF BONN   (Germany)

^g FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Angio oedema; Bradykinin; C1 inhibitor; High molecular weight kininogen; Oestrogen; Urticaria

Indexed keywords

BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; CYPROTERONE ACETATE PLUS ETHINYLESTRADIOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; EFEZIAL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; MELODIA; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; MEDICAL RECORD REVIEW; PATIENT REFERRAL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN METABOLISM; RECURRENT DISEASE; URTICARIA;

ANGIOEDEMA; BRADYKININ; COMPLEMENT C1 INHIBITOR PROTEIN; CONTRACEPTIVES, ORAL, HORMONAL; DIAGNOSIS, DIFFERENTIAL; ESTROGENS; FEMALE; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; RETROSPECTIVE STUDIES; URTICARIA;

EID: 84867741227     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000340029     Document Type: Article

References (32)

1. Grattan C, Powell S, Humphreys F: Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001; 144: 708-714. (Pubitemid 32374771)
2. Kaplan AP, Greaves MW: Angioedema. J Am Acad Dermatol 2005; 53: 373-388. (Pubitemid 41195957)
3. Frank MM: Hereditary angioedema. J Allergy Clin Immunol 2008; 121:S398-S401.
4. Wagenaar-Bos IG, Drouet C, Aygoren-Pursun E, Bork K, Bucher C, Bygum A, Farkas H, Fust G, Gregorek H, Hack CE, Hickey A, Joller-Jemelka HI, Kapusta M, Kreuz W, Longhurst H, Lopez-Trascasa M, Madalinski K, Naskalski J, Nieuwenhuys E, Ponard D, Truedsson L, Varga L, Nielsen EW, Wagner E, Zingale L, Cicardi M, van Ham SM: Functional C1-inhibitor diagnostics in hereditary angioedema: Assay evaluation and recommendations. J Immunol Methods 2008; 338: 14-20.
5. Zuraw BL, Herschbach J: Detection of C1 inhibitor mutations in patients with hereditary angioedema. J Allergy Clin Immunol 2000; 105: 541-546. (Pubitemid 30169913)
6. Bowen B, Hawk JJ, Sibunka S, Hovick S, Weiler JM: A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin Immunol 2001; 98: 157-163.
7. Castelli R, Deliliers DL, Zingale LC, Pogliani EM, Cicardi M: Lymphoproliferative disease and acquired C1 inhibitor deficiency. Haematologica 2007; 92: 716-718. (Pubitemid 350144284)
8. Zingale LC, Castelli R, Zanichelli A, Cicardi M: Acquired deficiency of the inhibitor of the first complement component: Presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 2006; 26: 669-690. (Pubitemid 44666305)
9. Chevailler A, Arlaud G, Ponard D, Pernollet M, Carrère F, Renier G, Drouet M, Hurez D, Gardais J: C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema. J Allergy Clin Immunol 1996; 97: 998-1008. (Pubitemid 26116995)
10. Bouillet L, Ponard D, Drouet C, Jullien D, Massot C: Angioedema and oral contraception. Dermatology 2003; 206: 106-109. (Pubitemid 36205275)
11. André F, Veysseyre-Balter C, Rousset H, Descos L, André C: Exogenous oestrogen as an alternative to food allergy in the aetiology of angioneurotic oedema. Toxicology 2003; 185: 155-160. (Pubitemid 36050738)
12. Bork K, Barnstedt SE, Koch P, Traupe H: Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000; 356: 213-217. (Pubitemid 30446977)
13. Binkley KE, Davis A 3rd: Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000; 106: 546-550. (Pubitemid 32037708)
14. Martin L, Degenne D, Toutain A, Ponard D, Watier H: Hereditary angioedema type III: An additional French pedigree with autosomal dominant transmission. J Allergy Clin Immunol 2001; 107: 747-748. (Pubitemid 32397773)
15. Cichon S, Martin L, Hennies HC, Müller F, Van Driessche K, Karpushova A, Stevens W, Colombo R, Renné T, Drouet C, Bork K, Nöthen MM: Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 2006; 79: 1098-1104. (Pubitemid 44853481)
16. Martin L, Raison-Peyron N, Nothen MM, Cichon S, Drouet C: Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J Allergy Clin Immunol 2007; 120: 975- 977. (Pubitemid 47531849)
17. Drouet C, Alibeu C, Ponard D, Arlaud G, Colomb M: A sensitive method to assay blood complement C1-inhibitor activity. Clin Chim Acta 1988; 174: 121-130.
18. Adam A, Cugno M, Molinaro G, Perez M, Lepage Y, Agostoni A: Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet 2002; 359: 2088- 2089. (Pubitemid 34680976)
19. Cyr M, Lepage Y, Blais C, Jr., Gervais N, Cugno M, Rouleau JL, Adam A: Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 2001; 281:H275-H283.
20. Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M: Epidemiology of urticaria: A representative cross-sectional population survey. Clin Exp Dermatol 2010; 35: 869-873.
21. Paul E, Greilich KD: Epidemiology of urticaria diseases. Hautarzt 1991; 42: 366-375.
22. Amy JJ, Tripathi V: Contraception for women: An evidence based overview. BMJ 2009; 339:b2895.
23. Erkkola R: Recent advances in hormonal contraception. Curr Opin Obstet Gynecol 2007; 19: 547-553. (Pubitemid 350135437)
24. Bork K, Fischer B, Dewald G: Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003; 114: 294-298. (Pubitemid 36398075)
25. Bork K, Gül D, Hardt J, Dewald G: Hereditary angioedema with normal C1 inhibitor: Clinical symptoms and course. Am J Med 2007; 120: 987-992. (Pubitemid 47633496)
26. Cicardi M, Bergamaschini L, Zingale LC, Gioffré D, Agostoni A: Idiopathic nonhistaminergic angioedema. Am J Med 1999; 106: 650-654. (Pubitemid 29279302)
27. Jorge AS, Dortas SD, Valle SO, Franca AT: Hereditary angioedema and chronic urticaria: Is there a possible association? J Investig Allergol Clin Immunol 2009; 19: 327-328.
28. Pichler WJ, Lehner R, Späth PJ: Recurrent angioedema associated with hypogonadism or anti-androgen therapy. Ann Allergy 1989; 63: 301-305. (Pubitemid 19266283)
29. Warin RP, Cunliffe WJ, Greaves MW, Wallington TB: Recurrent angioedema: Familial and oestrogen-induced. Br J Dermatol 1986; 115: 731-734. (Pubitemid 17181900)
30. Di Scipio RG, Hugli TE: The architecture of complement component C9 and poly(C9). J Biol Chem 1985; 260: 14802-14809.
31. Köhl J: The role of complement in danger sensing and transmission. Immunol Res 2006; 34: 157-176. (Pubitemid 43997968)
32. Oschatz C, Maas C, Lecher B, Jansen T, Björkqvist J, Tradler T, Sedlmeier R, Burfeind P, Cichon S, Hammerschmidt S, Müller-Esterl W, Wuillemin WA, Nilsson G, Renné T: Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity 2011; 34: 258-268.